ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is a particular type of breast cancer defined by the absence of estrogen and progesterone receptor expression as well as the absence of ERBB2 amplification, which accounts for 15% to 20% of breast cancers [5].